About
David S. Rosenthal is a Partner in the Corporate department at Dechert, based in the United States. He represents corporations, investment banks, and venture capital firms in the life sciences, medical device, technology, media, and growth sectors. His practice encompasses corporate finance, mergers and acquisitions, joint ventures, licensing, strategic alliances, public and private securities offerings (including IPOs, secondary offerings, CMPOs, ATM financings, registered direct offerings, PIPEs, seed and venture capital financings), and counseling foreign private issuers on U.S. stock exchange listings. He also advises on general corporate matters, SEC compliance, and corporate governance.
Practice areas
Corporate FinanceMergers and AcquisitionsJoint VenturesLicensingStrategic AlliancesSecuritiesPrivate PlacementsPublic OfferingsVenture CapitalLife SciencesTechnologyMediaCorporate GovernanceSEC Compliance
Office
Expertise
Corporate FinanceMergers and AcquisitionsJoint VenturesLicensingStrategic AlliancesSecurities OfferingsVenture CapitalLife SciencesMedical DeviceTechnologyMediaCorporate GovernanceSEC ComplianceForeign Private Issuers